ATLANTIC SAPPHIRE And SMARTPHOTO GROUP On The List Of Winners And Losers Of Friday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ATLANTIC SAPPHIRE, BELYSSE GROUP, and NYKODE THERAPEUTIC.

Financial Asset Price Change Updated (EST)
ATLANTIC SAPPHIRE (ASA.OL) 1.05 15.38% 2024-08-23 12:24:43
BELYSSE GROUP (BELYS.BR) 0.87 11.54% 2024-08-23 12:05:13
NYKODE THERAPEUTIC (NYKD.OL) 6.28 8.74% 2024-08-23 12:41:48
ADOCIA (ADOC.PA) 5.89 7.09% 2024-08-23 12:45:03
NAPATECH (NAPA.OL) 32.70 6.86% 2024-08-23 12:41:20
TREASURE (TRE.OL) 25.90 5.71% 2024-08-23 12:44:07
BW LPG (BWLPG.OL) 172.50 5.63% 2024-08-23 12:25:15
SCANA (SCANA.OL) 2.52 4.78% 2024-08-23 12:42:55
BORGESTAD (BOR.OL) 16.15 4.19% 2024-08-23 12:25:06
GALAPAGOS (GLPG.AS) 23.34 3.92% 2024-08-23 12:02:10

The three biggest losers today are SMARTPHOTO GROUP, BENEVOLENTAI, and ESTORIL SOL N.

Financial Asset Price Change Updated (EST)
SMARTPHOTO GROUP (SMAR.BR) 25.20 -7.01% 2024-08-23 12:21:28
BENEVOLENTAI (BAI.AS) 0.82 -6.82% 2024-08-23 12:00:55
ESTORIL SOL N (ESON.LS) 5.65 -6.61% 2024-08-23 12:23:09
INTEROIL EXPL PROD (IOX.OL) 3.35 -5.81% 2024-08-23 12:40:39
NRC GROUP (NRC.OL) 8.88 -5.53% 2024-08-23 12:41:46
LAVIDE HOLDING (LVIDE.AS) 0.24 -5.43% 2024-08-23 12:02:45
ELECTROMAGNET GEO (EMGS.OL) 2.53 -4.72% 2024-08-23 12:25:40
ARCTICZYMES TECHNO (AZT.OL) 20.80 -4.59% 2024-08-23 12:24:34
KLAVENESS COMBINAT (KCC.OL) 94.70 -4.25% 2024-08-23 12:40:52
ITERA (ITERA.OL) 11.50 -4.17% 2024-08-23 12:40:40

Winners today

1. ATLANTIC SAPPHIRE (ASA.OL)

15.38% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE rising 15.38% to €1.05 on Friday while Oslo Børs Benchmark Index_GI rose 0.67% to €1,434.48.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-25.31.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Volume

Today’s last reported volume for ATLANTIC SAPPHIRE is 1681900 which is 195.49% above its average volume of 569180.

Revenue Growth

Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 18.95M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be overbought (>=80).

Moving Average

ATLANTIC SAPPHIRE’s value is way under its 50-day moving average of kr6.29 and way below its 200-day moving average of kr6.74.

More news about ATLANTIC SAPPHIRE.

2. BELYSSE GROUP (BELYS.BR)

11.54% Price Change

Belysse Group NV engages in the production and sale of textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.

BEL 20 ended the session with BELYSSE GROUP rising 11.54% to €0.87 on Friday, following the last session’s downward trend. BEL 20 rose 0.09% to €4,112.91, after two consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.31.

Volatility

BELYSSE GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.76%, a negative 0.23%, and a positive 3.11%.

BELYSSE GROUP’s highest amplitude of average volatility was 3.19% (last week), 2.83% (last month), and 3.11% (last quarter).

More news about BELYSSE GROUP.

3. NYKODE THERAPEUTIC (NYKD.OL)

8.74% Price Change

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NYKODE THERAPEUTIC rising 8.74% to €6.28 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.67% to €1,434.48, after three successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, NYKODE THERAPEUTIC has a trailing twelve months EPS of kr-1.26.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.89%.

More news about NYKODE THERAPEUTIC.

4. ADOCIA (ADOC.PA)

7.09% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA jumping 7.09% to €5.89 on Friday while CAC 40 rose 0.7% to €7,577.04.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.96%, a negative 0.67%, and a positive 4.11%.

ADOCIA’s highest amplitude of average volatility was 2.57% (last week), 2.85% (last month), and 4.11% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 69.1%, now sitting on 6.05M for the twelve trailing months.

Yearly Top and Bottom Value

ADOCIA’s stock is valued at €5.89 at 22:40 EST, way under its 52-week high of €16.16 and way above its 52-week low of €5.11.

More news about ADOCIA.

5. NAPATECH (NAPA.OL)

6.86% Price Change

Napatech A/S offers reconfigurable computing solutions for the networking and cybersecurity applications worldwide. The company provides Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which offers a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions. It offers solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. Napatech A/S was incorporated in 2003 and is based in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH jumping 6.86% to €32.70 on Friday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.67% to €1,434.48, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-0.72.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.66%.

More news about NAPATECH.

6. TREASURE (TRE.OL)

5.71% Price Change

Treasure ASA, through its 11% interest in Hyundai Glovis Co. Ltd., provides transportation and logistics services in South Korea. The company was incorporated in 2016 and is based in Lysaker, Norway. Treasure ASA is a subsidiary of Wilh. Wilhelmsen Holding ASA.

Oslo Børs Benchmark Index_GI ended the session with TREASURE jumping 5.71% to €25.90 on Friday, after four consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.67% to €1,434.48, after three successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, TREASURE has a trailing twelve months EPS of kr4.52.

PE Ratio

TREASURE has a trailing twelve months price to earnings ratio of 5.73. Meaning, the purchaser of the share is investing kr5.73 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.89%.

Volume

Today’s last reported volume for TREASURE is 3149 which is 70.76% below its average volume of 10770.

Moving Average

TREASURE’s value is way above its 50-day moving average of kr20.21 and way above its 200-day moving average of kr20.31.

More news about TREASURE.

7. BW LPG (BWLPG.OL)

5.63% Price Change

BW LPG Limited, an investment holding company, engages in ship owning and chartering activities worldwide. The company operates through Shipping and Product Services segments. The company involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. It also offers integrated liquified petroleum gas (LPG) delivery services and support; wholesale and trade of LPG; and management services. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.

Oslo Børs Benchmark Index_GI ended the session with BW LPG rising 5.63% to €172.50 on Friday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.67% to €1,434.48, after three sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, BW LPG has a trailing twelve months EPS of kr39.13.

PE Ratio

BW LPG has a trailing twelve months price to earnings ratio of 4.41. Meaning, the purchaser of the share is investing kr4.41 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.16%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 26, 2023, the estimated forward annual dividend rate is 39.9 and the estimated forward annual dividend yield is 33.62%.

Sales Growth

BW LPG’s sales growth is 20.3% for the current quarter and 31.1% for the next.

More news about BW LPG.

8. SCANA (SCANA.OL)

4.78% Price Change

Scana ASA engages in the offshore, energy, and maritime businesses in Norway, rest of European countries, America, Asia, Africa, and Oceania. The company offers valve remote control systems and mooring solutions to vessels, rigs, and floating structures serving the shipping, aquaculture, oil and gas, and energy industries. It also engages in the design and integration of electrical power systems, electrical infrastructure, and energy storage systems and control systems. In addition, the company is involved in the planning and execution of insulation, scaffolding, and surface treatment services; and rig, capping, equipment support, make and break, IMR lifecycle, welding, and asset integrity management services to drilling industry, as well as offers riser applications to the oil and gas industry. Scana ASA was formerly known as Incus Investor ASA and changed its name to Scana ASA in May 2020. The company was founded in 1646 and is headquartered in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with SCANA jumping 4.78% to €2.52 on Friday while Oslo Børs Benchmark Index_GI jumped 0.67% to €1,434.48.

Earnings Per Share

As for profitability, SCANA has a trailing twelve months EPS of kr0.23.

PE Ratio

SCANA has a trailing twelve months price to earnings ratio of 10.96. Meaning, the purchaser of the share is investing kr10.96 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.92%.

Volatility

SCANA’s last week, last month’s, and last quarter’s current intraday variation average was 2.32%, 0.16%, and 1.34%.

SCANA’s highest amplitude of average volatility was 2.66% (last week), 1.54% (last month), and 1.34% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 35%, now sitting on 1.75B for the twelve trailing months.

More news about SCANA.

9. BORGESTAD (BOR.OL)

4.19% Price Change

Borgestad ASA develops, manufactures, distributes, delivers, and installs refractory products in Norway. The company also develops and manages real estate properties. It operates Agora Bytom, a shopping center and a rental area, as well as a parking garage with parking spaces in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.

Oslo Børs Benchmark Index_GI ended the session with BORGESTAD rising 4.19% to €16.15 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.67% to €1,434.48, after three successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.96.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Volatility

BORGESTAD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.80%, a positive 0.76%, and a positive 2.93%.

BORGESTAD’s highest amplitude of average volatility was 3.65% (last week), 4.32% (last month), and 2.93% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 400% and 100%, respectively.

More news about BORGESTAD.

10. GALAPAGOS (GLPG.AS)

3.92% Price Change

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

AEX-Index ended the session with GALAPAGOS rising 3.92% to €23.34 on Friday, following the last session’s downward trend. AEX-Index rose 0.02% to €908.56, after two sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, GALAPAGOS has a trailing twelve months EPS of €0.48.

PE Ratio

GALAPAGOS has a trailing twelve months price to earnings ratio of 48.62. Meaning, the purchaser of the share is investing €48.62 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.15%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GALAPAGOS’s stock is considered to be overbought (>=80).

Volatility

GALAPAGOS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.27%, a negative 0.49%, and a positive 1.30%.

GALAPAGOS’s highest amplitude of average volatility was 0.98% (last week), 1.57% (last month), and 1.30% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 362.5% and a negative 148.7%, respectively.

More news about GALAPAGOS.

Losers Today

1. SMARTPHOTO GROUP (SMAR.BR)

-7.01% Price Change

Smartphoto Group NV engages in the B2C e-commerce business in Europe. The company offers personalized products, including gifts, cards, photo books, photo calendars, prints, wall decoration, clothing, accessories, etc. under the smartphoto brand name. It engages in the e-commerce distribution of personalized gift packages with chocolate, alcohol, fruit, and flowers under the Nayan brand name through websites comprising Gift.be and GiftsforEurope.com. Smartphoto Group NV was founded in 1964 and is based in Wetteren, Belgium.

BEL 20 ended the session with SMARTPHOTO GROUP dropping 7.01% to €25.20 on Friday while BEL 20 jumped 0.09% to €4,112.91.

Earnings Per Share

As for profitability, SMARTPHOTO GROUP has a trailing twelve months EPS of €1.76.

PE Ratio

SMARTPHOTO GROUP has a trailing twelve months price to earnings ratio of 14.32. Meaning, the purchaser of the share is investing €14.32 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.15%.

Volatility

SMARTPHOTO GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.37%, a negative 0.10%, and a positive 1.14%.

SMARTPHOTO GROUP’s highest amplitude of average volatility was 1.11% (last week), 1.34% (last month), and 1.14% (last quarter).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 1.05 and the estimated forward annual dividend yield is 3.92%.

Yearly Top and Bottom Value

SMARTPHOTO GROUP’s stock is valued at €25.20 at 22:40 EST, below its 52-week low of €25.50.

Volume

Today’s last reported volume for SMARTPHOTO GROUP is 9300 which is 3095.88% above its average volume of 291.

More news about SMARTPHOTO GROUP.

2. BENEVOLENTAI (BAI.AS)

-6.82% Price Change

BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company's development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, an oral brain penetrant CHK1 inhibitor under preclinical study for the treatment of Glioblastoma Multiforme; BEN-34712, a preclinical candidate for the potential treatment of ALS; and various candidates for the treatment of fibrosis and Parkinson's disease. It has collaboration agreements with AstraZeneca and Merck to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI sliding 6.82% to €0.82 on Friday while AEX-Index jumped 0.02% to €908.56.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.63.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.01%.

Volatility

BENEVOLENTAI’s last week, last month’s, and last quarter’s current intraday variation average was 19.21%, 1.54%, and 5.52%.

BENEVOLENTAI’s highest amplitude of average volatility was 20.83% (last week), 6.31% (last month), and 5.52% (last quarter).

More news about BENEVOLENTAI.

3. ESTORIL SOL N (ESON.LS)

-6.61% Price Change

Estoril Sol, SGPS, S.A., together with its subsidiaries, engages in the gaming activities and real estate businesses in Portugal and internationally. It owns gaming casinos, including casino do Estoril, Casino Lisboa, and Casino da Póvoa. It is also involved in the online casino games and gambling business, as well as online sports betting activities. In addition, it owns a plot of land in Monte Estoril. Further, the company engages in tourism business. The company was incorporated in 1958 and is headquartered in Estoril, Portugal. Estoril Sol, SGPS, S.A. is a subsidiary of Finansol – Sociedade de Controlo, SGPS, S.A.

PSI ended the session with ESTORIL SOL N falling 6.61% to €5.65 on Friday while PSI jumped 0.8% to €6,698.07.

Earnings Per Share

As for profitability, ESTORIL SOL N has a trailing twelve months EPS of €0.47.

PE Ratio

ESTORIL SOL N has a trailing twelve months price to earnings ratio of 12.02. Meaning, the purchaser of the share is investing €12.02 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.72%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 224.92M for the twelve trailing months.

More news about ESTORIL SOL N.

4. INTEROIL EXPL PROD (IOX.OL)

-5.81% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company in Argentina and Colombia. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD sliding 5.81% to €3.35 on Friday while Oslo Børs Benchmark Index_GI rose 0.67% to €1,434.48.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr0.03.

PE Ratio

INTEROIL EXPL PROD has a trailing twelve months price to earnings ratio of 111.57. Meaning, the purchaser of the share is investing kr111.57 for every norwegian krone of annual earnings.

More news about INTEROIL EXPL PROD.

5. NRC GROUP (NRC.OL)

-5.53% Price Change

NRC Group ASA, together with its subsidiaries, operates as a rail infrastructure company in Norway, Sweden, and Finland. It offers groundwork services, including excavations, transport, masses sorting, and ditching, as well as water and drainage systems; and signaling systems, digital telecom systems, electro, tracks, and station buildings and terminals, as well as catenary systems comprising wires, masts, switches, and return current systems. The company also provides complementary services, such as concrete work, recycling, demolition, and mass transport services; and specialized trackwork services. In addition, it offers railway construction and maintenance, civil construction, and environmental services; related infrastructure services, including bridges and crossings; and electrical installations for rail, light rail, and metro systems. The company was formerly known as Blom ASA and changed its name to NRC Group ASA in May 2015. NRC Group ASA was founded in 1966 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with NRC GROUP dropping 5.53% to €8.88 on Friday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.67% to €1,434.48, after three successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, NRC GROUP has a trailing twelve months EPS of kr-0.17.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.5%.

Moving Average

NRC GROUP’s worth is way below its 50-day moving average of kr11.57 and way under its 200-day moving average of kr11.57.

More news about NRC GROUP.

6. LAVIDE HOLDING (LVIDE.AS)

-5.43% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. is based in Amsterdam, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING sliding 5.43% to €0.24 on Friday while AEX-Index rose 0.02% to €908.56.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.02.

Volume

Today’s last reported volume for LAVIDE HOLDING is 2400 which is 72.52% below its average volume of 8734.

Volatility

LAVIDE HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was 1.41%, 0.20%, and 4.15%.

LAVIDE HOLDING’s highest amplitude of average volatility was 4.01% (last week), 4.25% (last month), and 4.15% (last quarter).

Yearly Top and Bottom Value

LAVIDE HOLDING’s stock is valued at €0.24 at 22:40 EST, way under its 52-week high of €0.32 and way higher than its 52-week low of €0.18.

Moving Average

LAVIDE HOLDING’s value is below its 50-day moving average of €0.27 and way below its 200-day moving average of €0.27.

More news about LAVIDE HOLDING.

7. ELECTROMAGNET GEO (EMGS.OL)

-4.72% Price Change

Electromagnetic Geoservices ASA, together with its subsidiaries, provides electromagnetic (EM) surveying technology and services to the offshore oil and gas exploration industry. It is involved in the planning, acquisition, processing, modelling, interpretation, and integration of EM data. The company also uses its patented EM survey method to find hydrocarbons in offshore reservoirs. In addition, it engages in the provision of controlled-source EM surveying and magnetotelluric surveying; imaging and interpretation; rental of software and cluster; and training services. The company has operations in Europe, the Middle East, Africa, Norway, North and South America, Asia, and the Pacific Ocean. Electromagnetic Geoservices ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELECTROMAGNET GEO dropping 4.72% to €2.53 on Friday while Oslo Børs Benchmark Index_GI jumped 0.67% to €1,434.48.

Earnings Per Share

As for profitability, ELECTROMAGNET GEO has a trailing twelve months EPS of kr-0.84.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 145.52%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ELECTROMAGNET GEO’s EBITDA is 15.12.

Volume

Today’s last reported volume for ELECTROMAGNET GEO is 194457 which is 30.85% below its average volume of 281242.

More news about ELECTROMAGNET GEO.

8. ARCTICZYMES TECHNO (AZT.OL)

-4.59% Price Change

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; double-strand specific DNases and derived kits for the removal of double stranded DNA; DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It serves the molecular tools research and diagnostics, and biomanufacturing markets. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARCTICZYMES TECHNO falling 4.59% to €20.80 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.67% to €1,434.48, after three successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, ARCTICZYMES TECHNO has a trailing twelve months EPS of kr0.34.

PE Ratio

ARCTICZYMES TECHNO has a trailing twelve months price to earnings ratio of 61.18. Meaning, the purchaser of the share is investing kr61.18 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.15%.

More news about ARCTICZYMES TECHNO.

9. KLAVENESS COMBINAT (KCC.OL)

-4.25% Price Change

Klaveness Combination Carriers ASA owns and operates combination carriers for the dry bulk shipping and product tanker industries in the Middle East, Australia, Oceania, North East Asia, South America, North America, Europe, Southeast Asia, and South Asia. The company operates through Caustic Soda-Bulk (CABU) and (Clean Petroleum Product-Bulk (CLEANBU) segments. Its vessels transport caustic coda solution, floating fertilizer, molasses, clean petroleum products, heavy liquid cargoes, and various types of dry bulk commodities, such as alumina, bauxite, grains, salt, iron, ore, and coal. The company was formerly known as Klaveness Combination Carriers AS and changed its name to Klaveness Combination Carriers ASA in February 2019. The company was founded in 2018 and is headquartered in Oslo, Norway. Klaveness Combination Carriers ASA is a subsidiary of Rederiaksjeselskapet Torvald Klaveness.

Oslo Børs Benchmark Index_GI ended the session with KLAVENESS COMBINAT falling 4.25% to €94.70 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.67% to €1,434.48, after three consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, KLAVENESS COMBINAT has a trailing twelve months EPS of kr14.81.

PE Ratio

KLAVENESS COMBINAT has a trailing twelve months price to earnings ratio of 6.39. Meaning, the purchaser of the share is investing kr6.39 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.14%.

Sales Growth

KLAVENESS COMBINAT’s sales growth for the current quarter is negative 19.2%.

More news about KLAVENESS COMBINAT.

10. ITERA (ITERA.OL)

-4.17% Price Change

Itera ASA, together with its subsidiaries, develops and operates digital solutions for businesses and organizations in Norway, Sweden, Ukraine, Denmark, Czech Republic, Iceland, Poland, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company provides a range of services in the strategy and consulting, customer experience, and technology and cloud transformation areas. It serves banking and insurance, energy and utilities, industry and manufacturing, health and public services, technology and communication, and products and retail industries. The company was founded in 1989 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ITERA sliding 4.17% to €11.50 on Friday, after three sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.67% to €1,434.48, after three sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.59.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 19.49. Meaning, the purchaser of the share is investing kr19.49 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 63.44%.

More news about ITERA.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *